THÔNG TIN TÀI LIỆU
33 Hofman N, Tan HL, Alders M, et al Yield of molecular and clinical testing for arrhythmia syndromes: report of 15 years’ experience Circulation 2013;128(14):1513–1521 34 Colan SD, Lipshultz SE, Lowe AM, et al Epidemiology and cause-specific outcome of hypertrophic cardiomyopathy in children: findings from the pediatric cardiomyopathy registry Circulation 2007;115(6):773–781 35 Nugent AW, Daubeney PE, Chondros P, et al Clinical features and outcomes of childhood hypertrophic cardiomyopathy: results from a national population-based study Circulation 2005;112(9):1332–1338 36 Maron BJ, Rowin EJ, Casey SA, et al Hypertrophic cardiomyopathy in children, Adolescents, and young adults associated with low cardiovascular mortality with contemporary management strategies Circulation 2016;133(1):62–73 37 Lipshultz SE, Orav EJ, Wilkinson JD, et al Risk stratification at diagnosis for children with hypertrophic cardiomyopathy: an analysis of data from the pediatric cardiomyopathy registry Lancet 2013;382(9908):1889–1897 38 Harris KM, Spirito P, Maron MS, et al Prevalence, clinical profile, and significance of left ventricular remodeling in the end-stage phase of hypertrophic cardiomyopathy Circulation 2006;114(3):216–225 39 Maron BJ, Tajik AJ, Ruttenberg HD, et al Hypertrophic cardiomyopathy in infants: clinical features and natural history Circulation 1982;65(1):7–17 40 Ostman-Smith I, Wettrell G, Keeton B, et al Echocardiographic and electrocardiographic identification of those children with hypertrophic cardiomyopathy who should be considered at high-risk of dying suddenly Cardiol Young 2005;15(6):632–642 41 Olivotto I, Cecchi F, Casey SA, et al Impact of atrial fibrillation on the clinical course of hypertrophic cardiomyopathy Circulation 2001;104(21):2517–2524 42 Siontis KC, Geske JB, Ong K, et al Atrial fibrillation in hypertrophic cardiomyopathy: prevalence, clinical correlations, and mortality in a large high-risk population J Am Heart Assoc 2014;3(3):e001002 43 Maron BJ, Olivotto I, Bellone P, et al Clinical profile of stroke in 900 patients with hypertrophic cardiomyopathy J Am Coll Cardiol 2002;39(2):301–307 44 Cecchi F, Olivotto I, Gistri R, et al Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy N Engl J Med 2003;349(11):1027–1035 45 Olivotto I, Cecchi F, Gistri R, et al Relevance of coronary microvascular flow impairment to long-term remodeling and systolic dysfunction in hypertrophic cardiomyopathy J Am Coll Cardiol 2006;47(5):1043–1048 46 Olivotto I, Girolami F, Sciagra R, et al Microvascular function is selectively impaired in patients with hypertrophic cardiomyopathy and sarcomere myofilament gene mutations J Am Coll Cardiol 2011;58(8):839–848 47 Frank S, Braunwald E Idiopathic hypertrophic subaortic stenosis Clinical analysis of 126 patients with emphasis on the natural history Circulation 1968;37(5):759–788 48 Hardarson T, De la Calzada CS, Curiel R, Goodwin JF Prognosis and mortality of hypertrophic obstructive cardiomyopathy Lancet 1973;2(7844):1462–1467 49 McKenna W, Deanfield J, Faruqui A, et al Prognosis in hypertrophic cardiomyopathy: role of age and clinical, electrocardiographic and hemodynamic features Am J Cardiol 1981;47(3):532–538 50 Spirito P, Chiarella F, Carratino L, et al Clinical
Ngày đăng: 22/10/2022, 12:35
Xem thêm: